The Medicare Fair Prescription Drug Price Act of 2007 – the legislation that could help lower prescription drug costs for millions of Medicare beneficiaries – have been blocked from coming up for a vote on the Senate yesterday, despite the support of a majority of the U.S. Senate, and nearly 90 percent of voting-age Americans.
The AARP (a nonprofit, nonpartisan membership organization that helps people 50+ have independence, choice and control in ways that are beneficial and affordable to them and society as a whole) is very disappointed as expressed in its released statement.
According to David Sloane, AARP Director of Government Relations:
"Allowing Medicare to negotiate for lower drug prices is common sense, and could have led to more affordable drugs for Medicare beneficiaries and lower costs for all taxpayers.
Instead, a minority of the Senate decided to block consideration of a bill that has the support of the vast majority of their constituents.
Given the overwhelming support for giving Medicare the power to negotiate, the will of the people will eventually be heard."Read the full report for more details.
Comment Preview